The round was led by Salesforce Ventures, with participation from Echo Health Ventures and continued investment from Susa Ventures, Matrix Partners and HC9 Ventures, bringing total funding to over $25 milliom to date. The investment follows a momentum-driven seed round and validates what the market is already signaling: healthcare's AI moment has shifted from proof-of-concept to performance. Optura's platform is built for exactly that - to help organizations quickly assess AI business value and viability, prioritize AI investments and provide clear visibility into an AI's enterprise impact and return in real time.

Optura is the enterprise healthcare platform for ROAI™ (Return on AI Investment). Industry-trained and organization-specific, Optura is the C-suite's secret advantage for deciding where AI dollars actually pay off. It translates leadership priorities into operational AI agents built directly from existing workflows and SOPs, simulates the returns before a dollar is committed and tracks live performance against the projection on a unified intelligence layer. ROAI™ is the discipline that replaces directionless AI pilots with measurable performance, setting the modern standard for how healthcare leaders justify, fund and govern AI investment. More than $2B in healthcare AI initiatives run on Optura today, with $120M in tracked value at 700% ROAI™ on in-flight initiatives and over 250 new use cases identified. Optura is trusted by leading enterprise health plans and provider organizations.